Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.
Decock A, Ongenaert M, Cannoodt R, Verniers K, De Wilde B, Laureys G, Van Roy N, Berbegall AP, Bienertova-Vasku J, Bown N, Clément N, Combaret V, Haber M, Hoyoux C, Murray J, Noguera R, Pierron G, Schleiermacher G, Schulte JH, Stallings RL, Tweddle DA; Children’s Cancer and Leukaemia Group (CCLG); De Preter K, Speleman F, Vandesompele J.
Decock A, et al. Among authors: de wilde b, de preter k.
Oncotarget. 2016 Jan 12;7(2):1960-72. doi: 10.18632/oncotarget.6477.
Oncotarget. 2016.
PMID: 26646589
Free PMC article.